3) Higher sensitivity of detection of for example HER2 expression in qPCR gene panel analysis than in the PCR based AdnaTest Breast Cancer assay could lead to positive expression in “CTC negative” samples defined by commercial methods. This evidence concerns the gene ERBB2 and breast cancer.